Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 32 Records) |
Query Trace: Adenocarcinoma and KEAP1[original query] |
---|
Effects of Co-occurring Genomic Alterations on Outcomes in Patients with KRAS-Mutant Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Oct . Arbour Kathryn C, Jordan Emmett, Kim Hyunjae Ryan, Dienstag Jordan, Yu Helena A, Sanchez-Vega Francisco, Lito Piro, Berger Michael, Solit David B, Hellmann Matthew, Kris Mark G, Rudin Charles M, Ni Ai, Arcila Maria, Ladanyi Marc, Riely Gregory |
[Nrf2 and Keap1 Abnormalities in 104 Lung Adenocarcinoma Cases and Association with Clinicopathologic Features]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2018 Mar 21 (3): 241-250. Xiao Yu, Zhu Xiang, Gu Yangchun, Chen Sen, Liang Li, Cao Baosh |
Mutations in the KEAP1-NFE2L2 Pathway Define a Molecular Subset of Rapidly Progressing Lung Adenocarcinoma. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2019 7 14 (11): 1924-1934. Goeman Frauke, De Nicola Francesca, Scalera Stefano, Sperati Francesca, Gallo Enzo, Ciuffreda Ludovica, Pallocca Matteo, Pizzuti Laura, Krasniqi Eriseld, Barchiesi Giacomo, Vici Patrizia, Barba Maddalena, Buglioni Simonetta, Casini Beatrice, Visca Paolo, Pescarmona Edoardo, Mazzotta Marco, De Maria Ruggero, Fanciulli Maurizio, Ciliberto Gennaro, Maugeri-Saccà Marcel |
Harnessing Clinical Sequencing Data for Survival Stratification of Patients with Metastatic Lung Adenocarcinomas. JCO precision oncology 2019 3 . Shen Ronglai, Martin Axel, Ni Ai, Hellmann Matthew, Arbour Kathryn C, Jordan Emmet, Arora Arshi, Ptashkin Ryan, Zehir Ahmet, Kris Mark G, Rudin Charles M, Berger Michael F, Solit David B, Seshan Venkatraman E, Arcila Maria, Ladanyi Marc, Riely Gregory |
Systematic Identification of Multi Omics-based Biomarkers in KEAP1 Mutated TCGA Lung Adenocarcinoma. Journal of Cancer 2019 12 10 (27): 6813-6821. Namani Akhileshwar, Zheng Zhaohong, Wang Xiu Jun, Tang Xiuw |
PILAR1, a novel prognostic LncRNA, reveals the presence of a unique subtype of lung adenocarcinoma patients with KEAP1 mutations. Gene 2019 1 691 167-175. Kumar Pranjal, Khadirnaikar Seema, Shukla Sudhanshu Kum |
KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden. Annals of oncology : official journal of the European Society for Medical Oncology 2020 Aug . Marinelli D, Mazzotta M, Scalera S, Terrenato I, Sperati F, D'Ambrosio L, Pallocca M, Corleone G, Krasniqi E, Pizzuti L, Barba M, Carpano S, Vici P, Filetti M, Giusti R, Vecchione A, Occhipinti M, Gelibter A, Botticelli A, De Nicola F, Ciuffreda L, Goeman F, Gallo E, Visca P, Pescarmona E, Fanciulli M, De Maria R, Marchetti P, Ciliberto G, Maugeri-Saccà |
Differences in molecular epidemiology of lung cancer among ethnicities (Asian vs. Caucasian). Journal of thoracic disease 2020 Jul 12 (7): 3776-3784. Izumi Motohiro, Suzumura Tomohiro, Ogawa Koichi, Matsumoto Yoshiya, Sawa Kenji, Yoshimoto Naoki, Tani Yoko, Watanabe Tetsuya, Kaneda Hiroyasu, Mitsuoka Shigeki, Asai Kazuhisa, Kawaguchi Tomo |
Correction: STK11 and KEAP1 mutations as prognostic biomarkers in an observational real-world lung adenocarcinoma cohort. ESMO open 2020 6 5 (3): e000706corr1. Authors are not available |
EGFR-mutant lung adenocarcinoma harboring co-mutational tumor suppressor genes predicts poor prognosis. Journal of cancer research and clinical oncology 2020 May . Zhao Yue, Pan Yunjian, Cheng Chao, Zheng Difan, Zhang Yang, Gao Zhendong, Fu Fangqiu, Li Hang, Zheng Shanbo, Zhuge Lingdun, Mao Hengyu, Kuang Muyu, Tao Xiaoting, Peng Yizhou, Hu Hong, Xiang Jiaqing, Li Yuan, Sun Yihua, Chen Haiqu |
Construction of immune-related and prognostic lncRNA clusters and identification of their immune and genomic alterations characteristics in lung adenocarcinoma samples. Aging 2020 5 12 (10): 9868-9881. Li Jia, Zhang Chenyue, Zhang Chenxing, Wang Haiyo |
Less immune cell infiltration and worse prognosis after immunotherapy for patients with lung adenocarcinoma who harbored STK11 mutation. International immunopharmacology 2020 May 84 106574. Wang Haiyong, Guo Jun, Shang Xiaoling, Wang Zheh |
Phase 1 Trial of MLN0128 (Sapanisertib) and CB-839 HCl (Telaglenastat) in Patients With Advanced NSCLC (NCI 10327): Rationale and Study Design. Clinical lung cancer 2020 Oct . Riess Jonathan W, Frankel Paul, Shackelford David, Dunphy Mark, Badawi Ramsey D, Nardo Lorenzo, Cherry Simon R, Lanza Ian, Reid Joel, Gonsalves Wilson I, Kunos Charles, Gandara David R, Lara Primo N, Newman Edward, Paik Paul |
Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib. Scientific reports 2020 Nov 10 (1): 20243. Shang Yanhong, Li Xiaofang, Liu Weiwei, Shi Xiaoliang, Yuan Shaohua, Huo Ran, Fang Guotao, Han Xiao, Zhang Jingnan, Wang Kunjie, Dou Zhengyue, Zhang Yan, Zang Aimin, Zhang L |
Lung adenocarcinoma patients with KEAP1 mutation harboring low immune cell infiltration and low activity of immune environment. Thoracic cancer 2021 Jul . Cheng Wanwan, Xu Bin, Zhang Haitao, Fang Shenc |
Genetic and epigenetic landscape of leukocyte infiltration identifies an immune prognosticator in lung adenocarcinoma. Cancer biomarkers : section A of Disease markers 2021 Jul . Khadirnaikar Seema, Chatterjee Annesha, Shukla Sudhanshu Kum |
Efficacy of immunotherapy in KRAS-mutant non-small-cell lung cancer with comutations. Immunotherapy 2021 6 13 (11): 941-952. Davis Alexander P, Cooper Wendy A, Boyer Michael, Lee Jenny H, Pavlakis Nick, Kao Steven |
Treatment Patterns and Survival of Patients With Advanced Non-Small Cell Lung Cancer Guided by Comprehensive Genomic Profiling: Real-World Single-Institute Study in China. Frontiers in oncology 2021 11 630717. Lv Weize, Cheng Hua, Shao Di, Wei Yajun, Zhu Weiping, Wu Kui, Jiang Wenxi, Hu Liyang, Sha Zhou, Zhong Beilong, Pei Xiaofe |
Genetic Determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response In Vivo. Cancer discovery 2021 3 11 (7): 1736-1753. Foggetti Giorgia, Li Chuan, Cai Hongchen, Hellyer Jessica A, Lin Wen-Yang, Ayeni Deborah, Hastings Katherine, Choi Jungmin, Wurtz Anna, Andrejka Laura, Maghini Dylan G, Rashleigh Nicholas, Levy Stellar, Homer Robert, Gettinger Scott N, Diehn Maximilian, Wakelee Heather A, Petrov Dmitri A, Winslow Monte M, Politi Kateri |
An aging-related signature predicts favorable outcome and immunogenicity in lung adenocarcinoma. Cancer science 2021 12 113 (3): 891-903. Zhang Wenjing, Li Yuting, Lyu Juncheng, Shi Fuyan, Kong Yujia, Sheng Chao, Wang Suzhen, Wang Qingh |
Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2021 Nov . Ricciuti Biagio, Arbour Kathryn C, Lin Jessica J, Vajdi Amir, Vokes Natalie, Hong Lingzhi, Zhang Jianjun, Tolstorukov Michael Y, Li Yvonne Y, Spurr Liam F, Cherniack Andrew D, Recondo Gonzalo, Lamberti Giuseppe, Wang Xinan, Venkatraman Deepti, Alessi Joao V, Vaz Victor R, Rizvi Hira, Egger Jacklynn, Plodkowski Andrew J, Khosrowjerdi Sara, Digumarthy Subba, Park Hyesun, Vaz Nuno, Nishino Mizuki, Sholl Lynette M, Barbie David, Altan Mehmet, Heymach John V, Skoulidis Ferdinandos, Gainor Justin F, Hellmann Matthew D, Awad Mark |
Genomic Profiling Reveals Novel Predictive Biomarkers for Chemo-Radiotherapy Toxicity and Efficacy in Non-Small-Cell Lung Cancer. International journal of radiation oncology, biology, physics 2021 Nov 111 (3S): e437. He K, Zhang S, Pang J, Yin J, Zhang J, Mu D, Tang S, Li L, Bao H, Wu X, Wang X, Shao Y, Yu J, Yuan |
Clinicopathologic Characteristics and Outcomes for Patients With KRAS G12D-Mutant NSCLC. JTO clinical and research reports 2022 Sep 3 (9): 100390. Cooper Alissa J, Muzikansky Alona, Lennerz Jochen, Narinesingh Farhaana, Mino-Kenudson Mari, Hung Yin P, Piotrowska Zofia, Dagogo-Jack Ibiayi, Sequist Lecia V, Gainor Justin F, Lin Jessica J, Heist Rebecca |
Glutaminase inhibition impairs CD8 T cell activation in STK11-/Lkb1-deficient lung cancer. Cell metabolism 2022 5 34 (6): 874-887.e6. Best Sarah A, Gubser Patrick M, Sethumadhavan Shalini, Kersbergen Ariena, Negrón Abril Yashira L, Goldford Joshua, Sellers Katherine, Abeysekera Waruni, Garnham Alexandra L, McDonald Jackson A, Weeden Clare E, Anderson Dovile, Pirman David, Roddy Thomas P, Creek Darren J, Kallies Axel, Kingsbury Gillian, Sutherland Kate |
Next-generation Sequencing Reveals Age-dependent Genetic Underpinnings in Lung adenocarcinoma. Journal of Cancer 2022 4 13 (5): 1565-1572. Wu Xiaonan, Zhao Jun, Yang Ling, Nie Xin, Wang Zheng, Zhang Ping, Li Chao, Hu Xueqing, Tang Min, Yi Yuting, Du Xinhua, Xia Xuefeng, Guan Yanfang, Yu Zicheng, Gu Wenguang, Quan Xiangming, Li Lin, Shi Ho |
Multi-omics analysis identifies distinct subtypes with clinical relevance in lung adenocarcinoma harboring KEAP1/NFE2L2. Journal of Cancer 2022 4 13 (5): 1512-1522. Yang Xiaodong, Li Ming, Chen Zhencong, Fan Xiaobin, Guo Liang, Jin Bo, Huang Yiwei, Wang Qun, Wu Liang, Zhan Che |
Genomic and clinicopathological features of lung adenocarcinomas with micropapillary component. Frontiers in oncology 2022 12 12 989349. Li Peng, Liu Lu, Wang Dong, Yang Ronghua, Xuan Yunpeng, Han Yudong, Wang Jinglong, Guo Lijie, Zhang Liwen, Zhang Shanshan, Wang Yongj |
Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinoma. Annals of oncology : official journal of the European Society for Medical Oncology 2022 12 . Scalera S, Ricciuti B, Mazzotta M, Calonaci N, Alessi J V, Cipriani L, Bon G, Messina B, Lamberti G, Di Federico A, Pecci F, Milite S, Krasniqi E, Barba M, Vici P, Vecchione A, De Nicola F, Ciuffreda L, Goeman F, Fanciulli M, Buglioni S, Pescarmona E, Sharma B, Felt K D, Lindsay J, Rodig S J, De Maria R, Caravagna G, Cappuzzo F, Ciliberto G, Awad M M, Maugeri-Saccà |
Clear Cell Adenocarcinoma of Urethra: Clinical and Pathologic Implications and Characterization of Molecular Aberrations. Cancer research and treatment 2023 9 . Boram Song, Seok Hyun Lee, Jeong Hwan Park, Kyung Chul Mo |
Frequently mutated genes in predicting the relapse of stage I lung adenocarcinoma. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2023 2 . Rao Wen, Yang Lujie, Dai Nan, Zhang Liang, Liu Jie, Yang Bo, Li Mengxia, Shan Jinlu, Wang Qiushi, Wang Do |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: